Jin-qiao N. Zhang

Hebei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.

Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.

Journal: Cancer medicine

Published: February 01, 2025

Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.

Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.

Journal: Age and ageing

Published: April 17, 2021

Regulatory T cells in allogeneic hematopoietic stem cell transplantation: From the lab to the clinic.

Regulatory T cells in allogeneic hematopoietic stem cell transplantation: From the lab to the clinic.

Journal: Cellular immunology

Published: June 22, 2019

Association of increased microvessel density with skeletal extramedullary disease relapse in multiple myeloma patients who have skeletal extramedullary disease at diagnosis.

Association of increased microvessel density with skeletal extramedullary disease relapse in multiple myeloma patients who have skeletal extramedullary disease at diagnosis.

Journal: Pathology, research and practice

Published: May 19, 2018

Lenalidomide affect expression level of cereblon protein in multiple myeloma cell line RPMI8226.

Lenalidomide affect expression level of cereblon protein in multiple myeloma cell line RPMI8226.

Journal: Genetics and molecular research : GMR

Published: November 05, 2015

Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor.

Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor.

Journal: Molecular immunology

Published: September 25, 2015

Interleukin-17 receptor expression on vascular endothelial cells of masses of skeletal extramedullary disease in myeloma patients.

Interleukin-17 receptor expression on vascular endothelial cells of masses of skeletal extramedullary disease in myeloma patients.

Journal: Pathology, research and practice

Published: January 12, 2014

Norcantharidin induce anti-myeloma effect on nude mouse xenografts through NF-κB signal pathway

Norcantharidin induce anti-myeloma effect on nude mouse xenografts through NF-κB signal pathway

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 04, 2013

Expression levels of IL-27 and IL-17 in multiple myeloma patients: a higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival.

Expression levels of IL-27 and IL-17 in multiple myeloma patients: a higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival.

Journal: Leukemia research

Published: February 07, 2013

Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.

Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.

Journal: Leukemia & lymphoma

Published: August 15, 2012

Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway

Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: February 21, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026